CDP PROTEIN SECRETION INHIBITORS
rovided herein are compounds that inhibit protein secretion, e.g., via inhibition of Sec61. Also provided are compositions of the inhibitor compounds, and methods of using these inhibitors. The compounds disclosed herein can be used, e.g., for the treatment of cancer, arthritis, and/or inflammation....
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French |
Published |
03.10.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | rovided herein are compounds that inhibit protein secretion, e.g., via inhibition of Sec61. Also provided are compositions of the inhibitor compounds, and methods of using these inhibitors. The compounds disclosed herein can be used, e.g., for the treatment of cancer, arthritis, and/or inflammation.
L'invention concerne des composés qui inhibent la sécrétion de protéines, par exemple, par l'inhibition de Sec61. L'invention concerne également des compositions des composés inhibiteurs, et des procédés d'utilisation de ces inhibiteurs. Les composés de l'invention peuvent être utilisés, par exemple, pour le traitement du cancer, de l'arthrite et/ou de l'inflammation. |
---|---|
AbstractList | rovided herein are compounds that inhibit protein secretion, e.g., via inhibition of Sec61. Also provided are compositions of the inhibitor compounds, and methods of using these inhibitors. The compounds disclosed herein can be used, e.g., for the treatment of cancer, arthritis, and/or inflammation.
L'invention concerne des composés qui inhibent la sécrétion de protéines, par exemple, par l'inhibition de Sec61. L'invention concerne également des compositions des composés inhibiteurs, et des procédés d'utilisation de ces inhibiteurs. Les composés de l'invention peuvent être utilisés, par exemple, pour le traitement du cancer, de l'arthrite et/ou de l'inflammation. |
Author | TAUNTON, JOHN WILLIAM SHARP, PHILLIP PATRICK MCMINN, DUSTIN |
Author_xml | – fullname: TAUNTON, JOHN WILLIAM – fullname: SHARP, PHILLIP PATRICK – fullname: MCMINN, DUSTIN |
BookMark | eNrjYmDJy89L5WRQcHYJUAgI8g9x9fRTCHZ1DnIN8fT3U_D08_B08gzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxzo7GBpamJuaGjobGRCgBAJSgI0Q |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | INHIBITEURS DE SECRETION DE PROTEINE CDP |
ExternalDocumentID | CA3095471A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_CA3095471A13 |
IEDL.DBID | EVB |
IngestDate | Fri Nov 01 05:52:23 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_CA3095471A13 |
Notes | Application Number: CA20193095471 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191003&DB=EPODOC&CC=CA&NR=3095471A1 |
ParticipantIDs | epo_espacenet_CA3095471A1 |
PublicationCentury | 2000 |
PublicationDate | 20191003 |
PublicationDateYYYYMMDD | 2019-10-03 |
PublicationDate_xml | – month: 10 year: 2019 text: 20191003 day: 03 |
PublicationDecade | 2010 |
PublicationYear | 2019 |
RelatedCompanies | KEZAR LIFE SCIENCES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
RelatedCompanies_xml | – name: KEZAR LIFE SCIENCES – name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
Score | 3.2264943 |
Snippet | rovided herein are compounds that inhibit protein secretion, e.g., via inhibition of Sec61. Also provided are compositions of the inhibitor compounds, and... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | CDP PROTEIN SECRETION INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191003&DB=EPODOC&locale=&CC=CA&NR=3095471A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NS8Mw9DGm6G46FecXOUhvxWm7tD0UadOUVlhbuiq7jWxNYZdtuA7_vq-hm170FhJ4SR553x8BeHSaHuYWFfpQDEcqzKjbpWnrFZXIFEtDSlVbNU5o9G6-TUfTDiz3tTCqT-iXao6IFLVAeq8Vv978OLEClVu5fZovcWr9GhZuoLXWMRof-Eq1wHd5lgYp0xhzmacluWugKoF82END6Qi1aKshBv7hN0Upm98SJTyD4wyBrepz6MhVH07Z_uO1PpyM23g3DlvS214AYUFGsjwteJyQCWc5b5xLJE6i2I-LNJ9cAgl5wSIdt5odrjVj3uFQxhV00dqX10DoS0llZdulsKUppCVQoC4c4TxX1JKV4wxg8CeYm3_WbqHX4EfloRl30K0_d_Ie5Wk9f1CY-AY7P3WJ |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1NS8Mw9DGmOG86FednDtJbcdquH4cibZrS6vpBV2W3ka0p7DKHq_j3fQ3d9KK3kMBL8sj7_gjAnd30MDcNrg75cCTDjKpV6pZaGQKZYqkJIWur4sQIX_Xn6WjageW2Fkb2Cf2SzRGRohZI77Xk1-sfJ5Yvcys39_MlTr0_BYXjK611jMYHvlLF9xyWpX5KFUod6ipJ7mioSiAfdtFQ2kMN22yIgb15TVHK-rdECY5gP0Ngq_oYOmLVhx7dfrzWh4O4jXfjsCW9zQkQ6mcky9OCRQmZMJqzxrlEoiSMvKhI88kpkIAVNFRxq9nuWjPq7g6lnUEXrX1xDsR4LA1RWVbJLaFzYXIUqAub2w-VYYrKtgcw-BPMxT9rt9ALi3g8G0fJyyUcNriSOWnaFXTrj09xjbK1nt9IrHwD6N54fA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=CDP+PROTEIN+SECRETION+INHIBITORS&rft.inventor=TAUNTON%2C+JOHN+WILLIAM&rft.inventor=SHARP%2C+PHILLIP+PATRICK&rft.inventor=MCMINN%2C+DUSTIN&rft.date=2019-10-03&rft.externalDBID=A1&rft.externalDocID=CA3095471A1 |